Winston Kung - Sep 21, 2022 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Director
Signature
/s/ Maria Dobek, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
Sep 21, 2022
Transactions value $
$0
Form type
3
Date filed
9/22/2022, 05:54 PM
Previous filing
Apr 21, 2022
Next filing
Jan 30, 2023

No securities are beneficially owned.